Linjie Li
No. 154, Anshan Road
Xiaobailou, 300052, China
Xiaobailou, 300052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Toll-like receptor 7 constrains efferocytosis in myocardial injury.
Journal: Basic research in cardiology
Published: March 06, 2026
Comparative effectiveness and safety of proton pump inhibitors after myocardial infarction on dual antiplatelet therapy: Insights from a target trial emulation.
Journal: British journal of clinical pharmacology
Published: February 21, 2026
Mortality After ST-Segment-Elevated Myocardial Infarction Among Patients With and Without Standard Modifiable Cardiovascular Risk Factors in China.
Journal: Circulation. Population health and outcomes
Published: February 13, 2026
β-Blockers After Myocardial Infarction in Patients With Preserved Ejection Fraction: A Meta-Analysis.
Journal: JAMA cardiology
Published: January 07, 2026
Percutaneous ventricular assist devices in high-risk PCI for older adults: evidence and next steps.
Journal: Heart (British Cardiac Society)
Published: December 29, 2025
Artificial Intelligence for Cardiovascular Health in China: Landscape and Challenges.
Journal: JACC. Asia
Published: December 05, 2025
Enhanced Nutritional Support May Ameliorate Rivaroxaban-Related Rapid Renal Function Decline: New Insights from a Real-World Study.
Journal: Drug design, development and therapy
Published: August 29, 2025
Reply to letter to the editor: Real-world comparative effectiveness of angiotensin-neprilysin inhibition versus angiotensin receptor blockers in acute myocardial infarction.
Journal: International journal of cardiology
Published: July 22, 2025
Combined Triglyceride-Glucose and Triglyceride-Glucose-Body Mass Index with B-Type Natriuretic Peptide for Enhanced Prediction of Major Adverse Cardiovascular Events in ST-Elevation Myocardial Infarction Patients: A Retrospective Cohort Study.
Journal: Reviews in cardiovascular medicine
Published: June 19, 2025
Low-intensity versus moderate- to high-intensity lipid-lowering therapy after myocardial infarction in patients aged 80 years and older: A retrospective cohort study.
Journal: American journal of preventive cardiology
Published: June 17, 2025
Integrated metabolic-inflammatory risk assessment: HbA1c/HDL-c and hsCRP-to-albumin ratios synergistically predict major adverse cardiovascular events in post-PCI STEMI patients.
Journal: Lipids in health and disease
Published: April 27, 2025
Last Updated: 09/26/2026